Last updated on January 2019

A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101)


Brief description of study

This is a phase 3 randomized trial evaluating the anti-tumor activity and safety of avelumab in combination with axitinib and of sunitinib monotherapy, administered as first-line treatment, in patients with advanced renal cell carcinoma

Clinical Study Identifier: NCT02684006

Contact Investigators or Research Sites near you

Start Over

Pfizer CT.gov Call Center

Ballarat Day Procedure Centre
Wendouree, Australia

Pfizer CT.gov Call Center

Ballarat Oncology & Haematology Services
Wendouree, Australia

Pfizer CT.gov Call Center

Nova Pharmacy
Wendouree, Australia

Pfizer CT.gov Call Center

Lake Imaging
Ballarat, Australia
3.15miles

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.